CS logo
small CS logo
UF Health Center at Orlando Health

Orlando, Florida, United States

About UF Health Center at Orlando Health


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Altor BioScience
2
Total Rows: 1

Clinical Trials at UF Health Center at Orlando Health


During the past decade, UF Health Center at Orlando Health conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 YearsStarted TrialsCompleted Trails
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study of ALT-801 in Combination With Cisplatin and Gemcitabine in Muscle Invasive or Metastatic Urothelial Cancer
2011-06-01
2017-10-01
Unknown status
90
A Study of ALT-801 in Patients With Bacillus Calmette-Guerin (BCG) Failure Non-Muscle Invasive Bladder Cancer
2012-04-01
2018-03-01
Unknown status
52

Rows per page:

1–2 of 2

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "UF Health Center at Orlando Health" #1 collaborator was "James and Esther King Biomedical Research Program" with 1 trials as a collaborator and "National Cancer Institute (NCI)" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.
Created with Highcharts 11.1.0Top Leading SponsorsAltor BioScience: 2Altor BioScience: 2

Created with Highcharts 11.1.0Top CollaboratorsJames and Esther KingBiomedical ResearchProgram: 1James and Esther KingBiomedical ResearchProgram: 1National Cancer Institute (NCI): 1National Cancer Institute (NCI): 1

Clinical Trials Conditions at UF Health Center at Orlando Health


According to Clinical.Site data, the most researched conditions in "UF Health Center at Orlando Health" are "Malignant Tumor of Renal Pelvis" (1 trials), "Non-muscle Invasive Bladder Cancer" (1 trials), "Transitional Cell Carcinoma of Bladder" (1 trials), "Ureter Cancer" (1 trials) and "Urethra Cancer" (1 trials). Many other conditions were trialed in "UF Health Center at Orlando Health" in a lesser frequency.

Clinical Trials Intervention Types at UF Health Center at Orlando Health


Most popular intervention types in "UF Health Center at Orlando Health" are "Biological" (2 trials) and "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "ALT-801" (2 trials), "Gemcitabine" (2 trials) and "Cisplatin" (1 trials). Other intervention names were less common.

Clinical Trials Genders at UF Health Center at Orlando Health


The vast majority of trials in "UF Health Center at Orlando Health" are 2 trials for "All" genders.

Clinical Trials Status at UF Health Center at Orlando Health


Currently, there are NaN active trials in "UF Health Center at Orlando Health". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in UF Health Center at Orlando Health, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in UF Health Center at Orlando Health, 2 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 1: 2Phase 1: 2Phase 2: 2Phase 2: 2

Created with Highcharts 11.1.0Trials StatusUnknown status: 2Unknown status: 2